Liu Demin, Zhi Yaxin, Sun Wei, Ma Yanan, Ji Shuoyuan, Gu Guoqiang
Department of Cardiology, The Second Hospital of Hebei Medical University, 050000 Shijiazhuang, Hebei, China.
Department of Cardiology, Xingtai People's Hospital, 054031 Xingtai, Hebei, China.
Rev Cardiovasc Med. 2025 Jul 23;26(7):33469. doi: 10.31083/RCM33469. eCollection 2025 Jul.
Chronic total occlusion (CTO) poses a significant challenge in cardiovascular interventional therapy, owing to the complexity and difficulty involved, which limit the effectiveness of traditional treatment methods. Thus, innovative designs and application concepts of guidewires have expanded the possibilities for clinical intervention, resulting in significant improvements in treatment strategies for CTO. Recently, numerous studies have detailed the application experiences of various guidewires in CTO interventional therapy, including the performance characteristics, selection strategies, and differences in clinical outcomes. Nevertheless, despite these advancements, limitations remain in CTO treatment, such as low success rates and the risk of complications. Therefore, this article aims to review the current application experience of CTO guidewires. Moreover, by reviewing existing literature and summarizing clinical practices, this paper explores strategies to optimize guidewire selection and usage to enhance the success rate and safety of CTO interventional therapy and provide practical guidance for clinicians.
慢性完全闭塞病变(CTO)在心血管介入治疗中构成了重大挑战,这是由于其涉及的复杂性和难度,限制了传统治疗方法的有效性。因此,导丝的创新设计和应用理念拓展了临床干预的可能性,使CTO的治疗策略有了显著改进。最近,众多研究详细阐述了各种导丝在CTO介入治疗中的应用经验,包括性能特点、选择策略以及临床结果的差异。然而,尽管有这些进展,CTO治疗仍存在局限性,如成功率低和并发症风险。因此,本文旨在回顾CTO导丝的当前应用经验。此外,通过回顾现有文献并总结临床实践,本文探讨优化导丝选择和使用的策略,以提高CTO介入治疗的成功率和安全性,并为临床医生提供实际指导。